The largest database of trusted experimental protocols

Pad block it dest

Manufactured by Thermo Fisher Scientific
Sourced in United States

The PAd/BLOCK-iT-DEST is a laboratory equipment product designed for gene expression research. It is a plasmid used for the creation of recombinant DNA constructs. The core function of this product is to facilitate the directional cloning of DNA sequences into expression vectors.

Automatically generated - may contain errors

5 protocols using pad block it dest

1

Lentiviral and Adenoviral Knockdown of TUSC5

Check if the same lab product or an alternative is used in the 5 most similar protocols
For lentivirus production Mission shRNA (Sigma–Aldrich) against TUSC5 was used. For adenovirus production shRNAs against TUSC5 were designed (http://rnaidesigner.invitrogen.com/rnaiexpress/), cloned into pENTR-U6 and recombined into pAd-BLOCK-iT-DEST (Invitrogen). VAMP2 cDNA amplified from murine adipocyte cDNA was cloned into pCDNA3.1/V5-His. Primer/shRNA sequences are available upon request.
+ Open protocol
+ Expand
2

Adenoviral Transduction of Preadipocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adenoviral shRNA constructs were obtained by synthesizing the respective oligonucleotide sequences into pENTR-U6 followed by homologous recombination into the pAd-BlockIt-DEST (all Invitrogen) according to the manufacturer’s instructions. The final constructs were linearized with PacI and purified. After transfection in HEK293A cells using Lipofectamine 2000, virus was harvested 10 days post infection. Crude virus lysate was used to re-infect further HEK293A cells and final harvested virus was purified by column purification (Virapur). For adenoviral over-expression viruses, the respective genes were synthesized (HiGene Molecular Biotech) with a C-terminal HA-tag and cloned into pENTR_CMV (M. Montminy) with HindIII and XhoI. They were recombined into the same pAdBlockIT-DEST destination vector to obtain comparable transduction rates. Concentration of active virus particles was determined by a plaque assay as recommended by the virus purification manual. For viral transduction of preadipocytes, 1.25 · 106 pfu of virus in 50 μl OptiMEM with 1% Lipofectamine2000 were incubated for 30 min. The mixture was combined with 50 μl of cells at 12,500 cells/μl and added to a 96well. 4 h post transduction virus-containing medium was replaced by full growth medium.
+ Open protocol
+ Expand
3

Adenoviral Knockdown Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adenovirus vectors expressing nontargeting (NT) short hairpin RNA (shRNA; shNT), NEAT1-targeting shRNAs (shNEAT1a/b), and GABARAP-targeting shRNAs (shGBRPa/b) have been reported previously [10 (link)].
Adenovirus vectors expressing SOD2-targeting shRNAs (shSOD2a/b) were constructed as reported previously [8 (link)]. Briefly, oligo DNAs (Table S1) were ligated into BsaI-digested pENTR/U6-AmCyan1 with Ligation High version 2 (Toyobo, Osaka, Japan). Then, shRNA and AmCyan1-expressing cassettes were transferred by the LR reaction to pAd/BLOCK-iT-DEST (Thermo Fisher Scientific, Waltham, MA, USA). Adenovirus vectors were constructed by transfection of PacI-digested adenovirus plasmid DNA with LipofectAMINE2000 into 293A cells (Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer’s protocol. Adenovirus titer was determined by the infectious genome titration protocol [63 (link)]. When knocking down genes in irradiated cells, these adenoviruses were transduced immediately after irradiation.
+ Open protocol
+ Expand
4

Adenoviral vector construction for gene silencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
All oligo DNAs and primers used are shown in Table S1. A BsaI-linker was ligated into pENTR/U6 (Thermo Fisher Scientific), resulting in pENTR/U6-Bgl2. The pAmCyan1-C1 plasmid (Takara Bio, Shiga, Japan) was digested with BglII and BamHI and then self-ligated to remove the multi-cloning site, resulting in pAmCyan1-noMCS. The AmCyan1-expressing cassette was amplified by KOD-neo-plus (Toyobo, Osaka, Japan) with AmCyan primers. Following BamHI digestion, it was inserted into the BglII site of pENTR/U6-Bgl2, resulting in pENTR/U6-AmCyan1. After BsaI digestion of pENTR/U6-AmCyan1, non-targeting (NT) short hairpin RNAs (shRNAs) (shNT), NEAT1-targeting shRNAs (shNEAT1a/b), or GABARAP-targeting shRNAs (shGBRPa/b) were ligated with Ligation High ver.2 (Toyobo). The shRNA and AmCyan1-expressing cassettes were transferred by LR reaction to pAd/BLOCK-iT-DEST (Thermo Fisher Scientific). Adenovirus vectors were constructed by transfection of adenovirus plasmid DNAs into 293T cells with LipofectAMINE2000 (Thermo Fisher Scientific) according to the manufacturer’s protocol. The adenovirus titer was determined using the infectious genome titration protocol [55 (link)].
+ Open protocol
+ Expand
5

Adenovirus Vector Construction

Check if the same lab product or an alternative is used in the 5 most similar protocols
The construction of adenovirus vectors was previously reported [17 (link),18 (link),19 (link)]. In brief, shNT, shNEAT1a/b, or shSOD2a/b were ligated into BsaI-digested pENTR/U6-AmCyan1 with Ligation High version 2 (Toyobo, Osaka, Japan). These oligo DNAs are shown in Table S1. The shRNA and AmCyan1-expressing cassettes were transferred by the LR reaction to pAd/BLOCK-iT-DEST (Thermo Fisher Scientific, Waltham, MA, USA). Adenovirus vectors were constructed by transfecting adenovirus plasmid DNA with Lipofec-tAMINE2000 into 293A cells (Thermo Fisher Scientific) according to the manufacturer’s protocol. Adenovirus titer was determined by the infectious genome titration protocol [22 (link)]. Adenovirus transduction was performed at 200 multiplicities of infection 24 h after seeding.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!